|1|Beyond the limits of oxygen: effects of hypoxia in a hormone-independent prostate cancer cell line. (24167746)
Mamede A.C.... Botelho M.F.
|2|Validation of stem cell markers in clinical prostate cancer: I+6-Integrin is predictive for non-aggressive disease. (24375374)
Hoogland A.M.... van Leenders G.J.
|3|Long-term outcomes and toxicity in patients treated with brachytherapy for prostate adenocarcinoma younger than 60 years of age at treatment with minimum 10 years of follow-up. (23374803)
Buckstein M.... Stock R.G.
|4|Genetic variants in CASP3, BMP5, and IRS2 genes may influence survival in prostate cancer patients receiving androgen-deprivation therapy. (22844442)
Huang S.P.... Huang C.H.
|5|Nerve growth factor level in the prostatic fluid of patients with chronic prostatitis/chronic pelvic pain syndrome is correlated with symptom severity and response to treatment. (20883485)
Watanabe T.... Chancellor M.B.
|6|Treatment efficiency, outcome and surgical treatment problems in patients suffering from localized embryonal bladder/prostate rhabdomyosarcoma: a report from the Cooperative Soft Tissue Sarcoma trial CWS-96. (21370402)
Seitz G.... Fuchs J.
|7|Overexpression of aldo-keto reductase 1C2 is associated with disease progression in patients with prostatic cancer. (20840669)
Huang K.H.... Lee M.C.
|8|Efficacy and safety of combined treatment of prostatic adenoma with 5-alpha reductase and alpha-adrenoblockers]. (20169718)
Tkachuk V.N.... Mosoian M.S.
|9|Recruitment of HDAC4 by transcription factor YY1 represses HOXB13 to affect cell growth in AR-negative prostate cancers. (19013255)
Ren G.... Lu J.
|10|Will GnRH antagonists improve prostate cancer treatment? (19008119)
Huhtaniemi I.... Persson B.E.
|11|miR-200 regulates PDGF-D-mediated epithelial-mesenchymal transition, adhesion, and invasion of prostate cancer cells. (19544444)
Kong D.... Sarkar F.H.
|12|The evolving role of oestrogens and their receptors in the development and progression of prostate cancer. (19013008)
Bonkhoff H.... Berges R.
|13|Cigarette smoking and prostate cancer in a prospective US cohort study. (19706848)
Watters J.L.... Albanes D.
|14|Protein phosphatase and TRAIL receptor genes as new candidate tumor genes on chromosome 8p in prostate cancer. (18460741)
Hornstein M.... Schulz W.A.
|15|Degarelix: a novel gonadotropin-releasing hormone (GnRH) receptor blocker--results from a 1-yr, multicentre, randomised, phase 2 dosage-finding study in the treatment of prostate cancer. (18538469)
Van Poppel H.... Kold Olesen T.
|16|Activation of the osteopontin/matrix metalloproteinase-9 pathway correlates with prostate cancer progression. (19010864)
Castellano G.... Libra M.
|17|C-reactive protein as a prognostic marker for men with androgen-independent prostate cancer: results from the ASCENT trial. (18428198)
Beer T.M.... Chi K.N.
|18|Bony lesion with prostate cancer]. (18379023)
Kamiya N.... Ichikawa T.
|19|The dietary bioflavonoid, quercetin, selectively induces apoptosis of prostate cancer cells by down-regulating the expression of heat shock protein 90. (18726985)
Aalinkeel R.... Schwartz S.A.
|20|Peroxisome Proliferator-Activated Receptor-gamma Is a Potent Target for Prevention and Treatment in Human Prostate and Testicular Cancer. (18317513)
Matsuyama M.... Yoshimura R.
|21|Adult prostate sarcoma: a report of 6 cases with clinical analysis]. (17725305)
Wang K.F.... Zhang Y.
|22|Genetic background influences murine prostate gene expression: implications for cancer phenotypes. (17577413)
Bianchi-Frias D.... Nelson P.S.
|23|Prognostic relevance of increased Rac GTPase expression in prostate carcinomas. (17639041)
Engers R.... Gabbert H.E.
|24|APC I1307K and the risk of prostate cancer. (16537703)
Poynter J.N.... Gruber S.B.
|25|First- and second-line chemotherapy with docetaxel or mitoxantrone in patients with hormone-refractory prostate cancer: does sequence matter? (16456811)
Michels J.... Nguyen Chi K.
|26|Alteration of gene expression in response to bone morphogenetic protein-2 in androgen-dependent human prostate cancer LNCaP cells. (16391828)
Kumagai T.... Takeda K.
|27|Amplification of the urokinase gene and the sensitivity of prostate cancer cells to urokinase inhibitors. (16430655)
Helenius M.A.... Visakorpi T.
|28|Enzymatic prostatic acid phosphatase in the clinical staging of patients diagnosed with prostate cancer. (16161529)
Merrick G.S.... Adamovich E.
|29|Interleukin-6 is responsible for drug resistance and anti-apoptotic effects in prostatic cancer cells. (15162378)
Pu Y.S.... Kuo M.L.
|30|Arsenite induces p70S6K1 activation and HIF-1alpha expression in prostate cancer cells. (14971642)
Skinner H.D.... Jiang B.H.
|31|Dexamethasone enhances the cytotoxic effect of radioiodine therapy in prostate cancer cells expressing the sodium iodide symporter. (15001595)
Scholz I.V.... Spitzweg C.
|32|In vivo suppression of hormone-refractory prostate cancer growth by inositol hexaphosphate: induction of insulin-like growth factor binding protein-3 and inhibition of vascular endothelial growth factor. (14734476)
Singh R.P.... Agarwal R.
|33|Early versus delayed hormonal therapy for prostate specific antigen only recurrence of prostate cancer after radical prostatectomy. (14767288)
Moul J.W.... Soderdahl D.
|34|The role of thymidine phosphorylase (TP) mRNA expression in angiogenesis of prostate cancer. (12820387)
Kikuno N.... Igawa M.
|35|Can complexed prostate specific antigen and prostatic volume enhance prostate cancer detection in men with total prostate specific antigen between 2.5 and 4.0 ng./ml. (11371884)
Okihara K.... Babaian R.J.
|36|Interleukin-6 and prostate cancer progression. (11312117)
Smith P.C.... Keller E.T.
|37|Human prostate cancer and benign prostatic hyperplasia: molecular dissection by gene expression profiling. (11406537)
Luo J.... Isaacs W.B.
|38|Polymorphic CAG and GGN repeat lengths in the androgen receptor gene and prostate cancer risk: a population-based case-control study in China. (11016637)
Hsing A.W.... Chang C.
|39|Prostate specific antigen density for discriminating prostate cancer from benign prostatic hyperplasia in the gray zone of prostate-specific antigen. (10466060)
Uno H.... Kawada Y.
|40|Review of phase II hormone refractory prostate cancer trials. (10606280)
|41|Alpha1-adrenoceptors in testosterone-induced prostatic hypertrophy. (9489864)
Auger-Pourmarin L.... Chabrier P.E.
|42|P-cadherin is a basal cell-specific epithelial marker that is not expressed in prostate cancer. (9815605)
Jarrard D.F.... Isaacs W.B.
|43|Mutation of the tumor suppressor gene p53 in human prostate and bladder cancers--investigation by temperature gradient gel electrophoresis (TGGE). (9072541)
Schlechte H.H.... Loening S.A.
|44|Androgens regulate the expression of proliferating cell nuclear antigen posttranscriptionally in the human prostate cancer cell line, LNCaP. (8603399)
Perry J.E.... Tindall D.J.
|45|Microwave hyperthermia in benign prostatic hypertrophy: a controlled clinical trial. (7544207)
Venn S.N.... Tiptaft R.C.
|46|Vitamin D receptor expression, 24-hydroxylase activity, and inhibition of growth by 1alpha,25-dihydroxyvitamin D3 in seven human prostatic carcinoma cell lines. (9816072)
Miller G.J.... Moffat K.A.
|47|Growth modulation of human prostatic cancer cells by interleukin-1 and interleukin-1 receptor antagonist. (7656219)
Hsieh T.C.... Chiao J.W.
|48|Ectopic production of prostate specific antigen by a breast tumor metastatic to the ovary. (7523638)
Yu H.... Katsaros D.
|49|Serum gamma-seminoprotein determination in prostatic cancer. (1716404)
Shimazaki J.... Eto K.
|50|Distribution of specific binding of [3H]promegestone in benign prostatic hypertrophy in regard to age, race and histological differences. (6200694)
Bashirelahi N.... Young J.D.